| Literature DB >> 34063691 |
Agnieszka Jabłońska-Wawrzycka1, Patrycja Rogala1, Grzegorz Czerwonka2, Sławomir Michałkiewicz1, Maciej Hodorowicz3, Katarzyna Gałczyńska2, Beata Cieślak4, Paweł Kowalczyk5.
Abstract
The constantly growing resistance of bacteria to antibiotics and other antibacterial substances has led us to an era in which alternative antimicrobial therapies are urgently required. One promising approach is to target bacterial pathogens using metal complexes. Therefore, we investigated the possibility of utilizing series ofEntities:
Keywords: HS surface analysis; antibacterial and anti-biofilm activity; crystal structure; inhibition effect of catalase; manganese(II) complexes; structure–activity relationship
Year: 2021 PMID: 34063691 PMCID: PMC8124774 DOI: 10.3390/ijms22094847
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Thermoanalytical results (TG and DTG) of Mn-dipyCO-NO3.
| Step | TG Range/K | DTG max/K | Mass Loss | Assignment |
|---|---|---|---|---|
| I | 448–540 | 483 | 34.37 (32.93) | 0.98 dipyCO |
| II | 540–628 | 583 | 16.58 (16.81) | 2 NO2 |
| III | 628–1073 | 663 | 32.98 (34.38) | 1.02 dipyCO |
| Total | 83.93 (84.12) | Leaving MnO2 residue | ||
Figure 1Plot of χM T vs. T for the crystalline sample of Mn-dipyCO-NO3. The solid lines were theoretical ones.
Figure 2Molecular structure with the atom numbering scheme and coordination polyhedron of Mn-dipyCO-NO3.
Structural criteria used for assigning nitrate modes for the Mn-dipyCO-NO3 complex [Å, °].
| Criteria |
|
| Bidentate Nitrate |
|---|---|---|---|
| l2-l1 | 0.07 | 0.14 | <0.3 [ |
| A1-A2 | 2.78 | 6.33 | <14 [ |
| l3-l2 | 0.37 | 0.33 | >0.2 [ |
| A3 | 176.42 | 174.37 | >162 [ |
Figure 3Packing view of the coordination polyhedral system forming a rhombic 3D network and the geometry of C–H⋯π (black line) and N–O⋯π (green line) interactions (X-H⋯π and Y-X⋯π interactions, view along [010] direction)—(a), and π⋯π stacking interaction—(b) for Mn-dipyCO-NO3. Cg(1) denotes the gravity ring center of N(31)-C(32)-C(33)-C(34)-C(35)-C(36); Cg(2) denotes the gravity ring center of C(12)-N(11B)-C(16B)-C(15)-C(14B)-C(13B); Cg(3) denotes the gravity ring center of N(21)-C(22)-C(23)-C(24)-C(25)-C(26).
Figure 4The Hirshfeld surfaces of series of the Mn(II) complexes mapped with 3D dnorm (with transparency enabled).
Figure 5The plots for the most significant intermolecular interaction within the series of the Mn(II) complexes showing percentages of contacts contributing to the total HS area.
Figure 6Cyclic voltammograms of the Mn-pyOH-NO3, Mn-imCHO-NO3, Mn-imCHO-Cl, and Mn-dipyCO-NO3 recorded at scan rates from 4.20 to 50 mV s−1 in CH3CN/glacial CH3COOH solution containing 0.1 M TBAPF6 (CV conditions: BDDE, Ø = 3 mm, T = 25 °C).
Figure 7The voltametric curves (V = 6.25 mV s−1) showing the comparison of the anodic peaks related to oxidation of Mn(II)/Mn(III) for Mn-pyOH-NO3, Mn-imCHO-NO3, Mn-imCHO-Cl, and Mn-dipyCO-NO3.
Figure 8P. aeruginosa PAO1 biofilm formation in the presence of the Mn(II) complexes, free ligands, and Mn(II) salts (concentrations of compounds—1–0.125 mM). The absorbance of the control was considered to represent 100% of biofilm formation (results were considered significant when compared to control; * p < 0.05. Data are presented as mean ± SD, n = 4).
Figure 9Epifluorescence microscopy images of P. aeruginosa PAO1 biofilm treated with 0.5 mM of the manganese complexes. Biofilm was stained with nucleic acid stains using the FilmTracer™ LIVE/DEAD Biofilm Viability kit (live cells are represented by the color green; dead cells are represented by the color red). The epifluorescence microscopy images were captured at 1000× magnification.
Figure 10Level of pyoverdine secretion by P. aeruginosa strains after incubation with the manganese complex, and streptomycin as a positive control, with an untreated sample as the negative control.
Figure 11Analysis of VH10 cell count over time following the Mn(II) complexes treatment acquired using the HoloMonitorM4.
Figure 12The effect of the Mn(II) complexes on the catalase activity.
Scheme 1Modification in the series of the Mn(II) complexes.
Correlation between selected structural parameters and anti-biofilm activity for the Mn(II) complexes.
| Complex | Mn-N (Ligand) [Å] | Mn-O (Ligand) [Å] | Space Group | ∠ N-C-C-O [°] | ∠ N-Mn-O Chelate [°] | ∠ O-Mn-O Chelate [°] | CN | % Inhibit. Biofilm (0.5 mM) | % Inhibit. Biofilm (0.25 mM) |
|---|---|---|---|---|---|---|---|---|---|
| Mn-pyOH-NO3 | 2.2792(1) | 2.2296(1) | 7.31 | 71.36 | 51.36 |
| 54 | 49 | |
| [Mn-pyOH-SO4]n | 2.247(2) | 2.2325(2) | −26.23 | 72.37 | – |
| 53 | 48 | |
| Mn-imCHO-NO3 | 2.2185(1) | 2.3897(1)-2.4693(1) |
| −2.91 | 71.4 | 49.03 |
| 56 | 52 |
| Mn-imCHO-Cl | 2.2254(2) | 2.3955(2) |
| −1.14 | 69.41 | – |
| 29 | 24 |
| Mn-pyCOOH-H2O | 2.2805(1) | 2.1390(1) |
| −14.22 | 74.13 | – |
| 48 | 45 |
| [Mn-pyCOOH-H2O]n | 2.2630(4) | 2.137(3), 2.167(3) | 2.88 | 74.72 | – |
| 45 | 44 | |
| Mn-dipyCO-NO3 | 2.2715(2) | 2.3144(2) |
| −3.14 | 69.25 | 54.34 |
| 36 | 21 |
Figure 13Correlation between the oxidation potential (Epa) for the Mn(II)/Mn(III) couple and the percentage biofilm inhibition against P. aeruginosa PAO1 strain.